美国65岁及以上退伍军人COVID-19与流感住院后30天死亡率比较
该回顾性研究纳入美国退伍军人健康系统中15,474例COVID-19住院和7,867例流感住院的65岁及以上退伍军人。COVID-19组粗30天死亡率为18.9%,流感组为4.3%;校正混杂因素后,COVID-19相对于流感的30天死亡比值比为6.61。研究还发现感染类型与衰弱存在显著交互作用。
要点
- COVID-19住院老年退伍军人的粗30天死亡率(18.9%)明显高于流感住院者(4.3%)。
- 校正混杂因素后,COVID-19相对流感的30天死亡OR为6.61(95%CI 5.74-7.65)。
- 两个队列中,年龄增长和衰弱程度较高均与30天死亡率升高显著相关。
核心结论
- 在住院老年退伍军人中,COVID-19的死亡率超过流感,但流感住院者在各衰弱水平上的死亡比值均高于COVID-19住院者。
- 预防仍是降低老年人病毒性疾病死亡率的关键。
研究设计与样本
- COVID-19由阳性PCR检测确定,流感由VA系统所用检测确定;衰弱由基于索赔数据的退伍军人事务部衰弱指数(VA-FI)定义。
- 采用logistic回归分析死亡率与衰弱、年龄和感染类型的关系,并校正多种混杂因素。
主要发现
- 共纳入15,474例COVID-19住院和7,867例流感住院退伍军人;COVID-19组平均(SD)年龄76.1(7.8)岁,流感组75.8(8.3)岁。
- COVID-19组97.7%为男性、66.9%为白人;流感组97.4%为男性、76.4%为白人。
- 粗30天死亡率(95%CI)COVID-19为18.9%(18.3%-19.5%),流感为4.3%(3.8%-4.7%)。
- 合并队列后,COVID-19相对流感的30天死亡OR为6.61(5.74-7.65)。
- COVID-19与衰弱之间存在统计学显著交互作用,但COVID-19与年龄之间无显著交互作用;两个队列中较老年龄和衰弱(相对健壮)均与30天死亡率升高显著相关(年龄p均<0.001;衰弱趋势p均<0.001)。
关键数值与推荐
- 粗30天死亡率:COVID-19为18.9%(95%CI 18.3%-19.5%),流感为4.3%(95%CI 3.8%-4.7%)。
- COVID-19相对流感的30天死亡OR为6.61(95%CI 5.74-7.65)。
- 年龄与30天死亡率关联的p值:COVID-19<0.001,流感<0.001;衰弱趋势p值:COVID-19<0.001,流感<0.001。
临床怎么用
- 对住院老年患者应重视病毒感染(COVID-19与流感)的死亡风险,尤其在高龄和衰弱人群中。
- 衰弱评估(如VA-FI)有助于识别住院老年病毒感染患者中的高风险个体。
- 预防接种等预防措施应作为降低老年人病毒性疾病死亡率的重要策略。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COVID-19 and influenza are important sources of morbidity and mortality among older adults. Understanding how outcomes differ for older adults hospitalized with either infection is important for improving care. We compared outcomes from infection with COVID-19 and influenza among hospitalized older adults. METHODS: We conducted a retrospective study of 30-day mortality among veterans aged 65+ hospitalized with COVID-19 from March 1, 2020-December 31, 2020 or with influenza A/B from September 1, 2017 to August 31, 2019 in Veterans Affairs Health Care System (VAHCS). COVID-19 infection was determined by a positive PCR test and influenza by tests used in the VA system. Frailty was defined by the claims-based Veterans Affairs Frailty Index (VA-FI). Logistic regressions of mortality on frailty, age, and infection were adjusted for multiple confounders. RESULTS: A total of 15,474 veterans were admitted with COVID-19 and 7867 with influenza. Mean (SD) ages were 76.1 (7.8) and 75.8 (8.3) years, 97.7% and 97.4% were male, and 66.9% and 76.4% were white in the COVID-19 and influenza cohorts respectively. Crude 30-day mortality (95% CI) was 18.9% (18.3%-19.5%) for COVID-19 and 4.3% (3.8%-4.7%) for influenza. Combining cohorts, the odds ratio for 30-day mortality from COVID-19 (versus influenza) was 6.61 (5.74-7.65). There was a statistically significant interaction between infection with COVID-19 and frailty, but there was no significant interaction between COVID-19 and age. Separating cohorts, greater 30-day mortality was significantly associated with older age (p: COVID-19: <0.001, Influenza: <0.001) and for frail compared with robust individuals (p for trend: COVID-19: <0.001, Influenza: <0.001). CONCLUSION: Mortality from COVID-19 exceeded that from influenza among hospitalized older adults. However, odds of mortality were higher at every level of frailty among those admitted with influenza compared to COVID-19. Prevention will remain key to reducing mortality from viral illnesses among older adults.
引用
- Seligman B, Charest B, Ho YL, et al. 30-day mortality following COVID-19 and influenza hospitalization among US veterans aged 65 and older. J Am Geriatr Soc. 2022. PMID: 35474510. doi:10.1111/jgs.17828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。